The Annual Vaccine and Immunotherapy Center Symposium is being held on January 25th, 2019 in the O’Keefe Auditorium at MGH and we would be delighted if you can join us.
The Plenary speakers in the first-morning session between 8:00 AM and 9:30 PM will be Dr. William Carson, President, and CEO of Otsuka Pharmaceutical Development and Commercialization, Inc. and Dr. George Savage, Cofounder and CMO of Proteus Digital Health, Inc. Bill and Georges’ talk is titled ‘Digital Medicine: Journey from Silicon Valley to FDA Approval.’
The later morning session beginning at 10:30 AM will feature presentations from VIC team leaders highlighting their current translational research projects and their development of new vaccines and immunotherapies for infectious diseases, cancer, and type 1 diabetes.
The Round Table panel discussion beginning at 1:30 PM, will be moderated by Dr. Dennis Brown, the Director of the MGH Office of Research Career Development on the topic of ‘Building Research Career Success at the Interface Between the Bench and the Bedside. Panel members will be Drs. Sylvie Breton, Nick Dyson, Tayyaba Hasan, and Ruxandra Sîrbulescu. This will be of particular interest to Ph.D. scientists at MGH and their mentors.
Vaccine and Immunotherapy Center
Division of Infectious Diseases, Department of Medicine
January 25, 2019, 8:00 AM—3:30 PM
|8:00 AM||Arrival, coffee, and pastries|
|8:10 AM – 9:30 AM||Plenary Session
Digital Medicine: Journey from Silicon Valley to FDA Approval
|Introduction||Mark Poznansky, MD, PhD; VIC Director|
|Plenary Speakers||Dr. William Carson, President, and CEO of Otsuka Pharmaceutical Development and Commercialization, Inc.
Dr. George Savage, Cofounder, and CMO of Proteus Digital Health, Inc
|9:30 AM -10:00 AM||Break|
|10:00 AM -12:30 PM||Presentations from VIC’s Senior Scientists|
|10:00 AM||Introductions||Mark Poznansky, MD, Ph.D.; VIC Director
Ann Sluder, Ph.D.; VIC Associate Director
|10:10 AM||Fighting Ebola with Rock-Hard mAbs; Low-Cost Biologics for All.||Michael V. Callahan, MD, DTM&H, MSHP;
Director, Research Translation, VIC. Department of Medicine, MGH
|10:30 AM||First – In Man, Controlled Trial of a Laser Vaccine Adjuvant on Human Immune Cell Trafficking||Jeffrey A. Gelfand, MD; VIC Senior Advisor and Scientist|
|10:50 AM||High-Dimensional Immunology to Drive Therapeutic and Vaccine Development in Infectious Diseases and Cancer||Patrick Reeves, Ph.D.; Instructor of Medicine|
|11:10 AM||Antimicrobial Resistance: Is There a (Blue) Light at the End of the Tunnel?||Tianhong Dai, Ph.D.; Assistant Professor, Wellman Center for Photomedicine and VIC Associate Member|
|11:30 AM||De-Stealthing Cancer with Novel Immunotherapeutic Agents||Huabiao Chen, MD; Instructor of Medicine|
|11:50 AM||Replacing Pancreatic Islets to Cure Type 1 Diabetes Without Systemic Immune Suppression||David Alagpulinsa, Ph.D.; VIC Research Fellow|
|12:10 PM||New Paths Towards Tissue Regeneration: B Cell Immunology||Ruxandra Sîrbulescu, Ph.D.; Instructor of Medicine|
|12:30 PM||Lunch break|
|1:30 PM -3:30 PM||Round Table
Building Research Career Success at the Interface Between the Bench and the Bedside
Dennis Brown, Ph.D.; Director of the MGH Office of Research Career Development
Nicholas Dyson, Ph.D.; Professor of Medicine, Mary B. Saltonstall Chair in Oncology, HMS, Scientific Director, Mass General Cancer Center, James, and Shirley Curvey MGH Research Scholar.
Tayyaba Hasan, Ph.D.; Professor of Dermatology, The Wellman Center of Photomedicine, HMS and Professor of Health Sciences and Technology (Harvard-MIT)
Sylvie Breton, Ph.D.; Professor of Medicine, HMS, Charles, and Ann Sanders MGH Research Scholar
Ruxandra Sîrbulescu, Ph.D.; Instructor of Medicine, HMS and Researcher, MGH